Searched for
US CANCER PATIENT
Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Quote of the Day by Soviet film-maker Andrei Tarkovsky: ‘Weakness is a great thing, and strength is nothing; when a man is just born, he is…’ - why being flexible may be stronger than being toughQuote of the Day by Andrei Tarkovsky: A reflection from Stalker (1979) explores why flexibility may be one of life's greatest strengths. Th...
- Doctors find new non-surgical treatment for osteoarthritis patients that may relieve knee pain in weeksA groundbreaking minimally invasive procedure, knee embolization, is offering new hope for knee osteoarthritis sufferers. Developed by Colu...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- How many Americans can afford high-quality healthcare? A new poll finds the number has fallenAmericans face growing challenges affording healthcare. New data reveals a significant drop in those able to manage medical costs and acces...
- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...
- Quote of the Day by Welsh poet Dylan Thomas: 'Do not go gentle into that good night, old age should…' - the raging verse that Bob Dylan, The Beatles, and Christopher Nolan honoredQuote of the Day by Dylan Thomas urges people to resist life's inevitable decline. In today's world of burnout, his words champion a fierce...
- Kindness act of the day from America: Dying man's final wish for hospice nurses gets fulfilled by New York restaurant ownerA touching act of kindness from New York continues to inspire months after it happened. Before his death, hospice patient Frank Ozimek aske...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.
- Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
Load More
